Vanguard Group Inc. Grows Stock Holdings in TG Therapeutics, Inc. (NASDAQ:TGTX)

Vanguard Group Inc. increased its stake in TG Therapeutics, Inc. (NASDAQ:TGTX – Free Report) by 1.4% during the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission. The fund owned 15,596,480 shares of the biopharmaceutical company’s stock after purchasing an additional 209,190 shares during the quarter. Vanguard Group Inc. owned […]